Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Canagliflozin

Hazard 5 P 3 B 0 T 2 Risk Insignificant

Information

The risk classification is based on total sold amount (kg) of the substance expected to be sold in Sweden in 2015

Author: Health and Medical Care Administration, Region Stockholm